FDA Approved Weight Loss Drugs: Why Semaglutide Leads The Market
Understanding Semaglutide’s Dominance in FDA Approved Weight Loss Medications The landscape of FDA approved weight loss drugs has evolved significantly with the introduction of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management. Semaglutide’s superior efficacy in inducing sustained weight loss has positioned it as a market leader, reshaping therapeutic … Read more